Jose Manuel Correia de Simas - 03 Mar 2025 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President, US Farm Animal Business
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Jose Manuel Correia de Simas
Issuer symbol
ELAN
Transactions as of
03 Mar 2025
Net transactions value
$0
Form type
4
Filing time
05 Mar 2025, 18:51:20 UTC
Previous filing
04 Mar 2025
Next filing
11 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +22,105 +37% $0.000000 81,400 03 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option (right to buy) Award $0 +46,383 $0.000000 46,383 03 Mar 2025 Common Stock 46,383 $11.31 Direct F2
transaction ELAN Deferred Stock Units (Match) Award $0 +1,830 $0.000000 1,830 03 Mar 2025 Common Stock 1,830 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028.
F2 Grant of stock options vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028.
F3 Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F4 Deferred stock units vest December 31, 2026 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan.

Remarks:

Executive Vice President, US Farm Animal Business